These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11206477)

  • 21. Catalytic antibodies for complex reactions: hapten design and the importance of screening for catalysis in the generation of catalytic antibodies for the NDA/CN reaction.
    DeSilva BS; Orosz G; Egodage KL; Carlson RG; Schowen RL; Wilson GS
    Appl Biochem Biotechnol; 2000; 83(1-3):195-206; discussion 206-8, 297-313. PubMed ID: 10826960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme may blunt cocaine's action.
    Morell V
    Science; 1993 Mar; 259(5103):1828. PubMed ID: 8456310
    [No Abstract]   [Full Text] [Related]  

  • 23. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of artificial enzymes to the problem of cocaine.
    De Prada P; Winger G; Landry DW
    Ann N Y Acad Sci; 2000; 909():159-69. PubMed ID: 10911929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review.
    Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M
    Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy for cocaine addiction.
    Landry DW
    Sci Am; 1997 Feb; 276(2):42-5. PubMed ID: 9000762
    [No Abstract]   [Full Text] [Related]  

  • 35. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats.
    Mets B; Winger G; Cabrera C; Seo S; Jamdar S; Yang G; Zhao K; Briscoe RJ; Almonte R; Woods JH; Landry DW
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10176-81. PubMed ID: 9707620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpected acetylcholinesterase activity of cocaine esterases.
    Rogers CJ; Eubanks LM; Dickerson TJ; Janda KD
    J Am Chem Soc; 2006 Dec; 128(48):15364-5. PubMed ID: 17131989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.
    Pan Y; Gao D; Zhan CG
    J Am Chem Soc; 2008 Apr; 130(15):5140-9. PubMed ID: 18341277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.